Wealth Enhancement Trust Services’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Wealth Enhancement Trust Services's IBB Position: Q3 2026 in Review
Wealth Enhancement Trust Services held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 55 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #587.
Wealth Enhancement Trust Services first reported a position in IBB in Q4 2025 and has held it in 4 quarters since. 1,019 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Wealth Enhancement Trust Services held 55 shares of iShares Biotechnology ETF worth $11.6K as of Q3 2026.
- Wealth Enhancement Trust Services left its iShares Biotechnology ETF share count unchanged in Q3 2026.
- iShares Biotechnology ETF made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q3 2026, its #587 holding.
- Wealth Enhancement Trust Services first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 4 quarters since.
- 1,019 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.